Development and validation of a novel Simoa assay for NPTX2 in Alzheimer's disease and Down syndrome. Sauer M, Gomes BF, Shahrouki P, Lantero-Rodriguez J, et al. Alzheimers Dement 2025;21:e70241.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Sauer M, Gomes BF, Shahrouki P, Lantero-Rodriguez J, et al. Development and validation of a novel Simoa assay for NPTX2 in Alzheimer's disease and Down syndrome. Alzheimers Dement 2025;21:e70241.
PMID: 40522075